Keywords: آسیب کبدی ناشی از مواد مخدر; Drug-induced liver injury; Hepatotoxicity; Gender differences; Drug property; Spontaneous adverse event reporting system; Liver events, and pharmacovigilance; DILI; drug-induced liver injury; DILIN; drug-induced liver injury network; HC; hepatocellular; C
مقالات ISI آسیب کبدی ناشی از مواد مخدر (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: آسیب کبدی ناشی از مواد مخدر; ALT; alanine aminotransferase; DILI; drug-induced liver injury; HBV; hepatitis B virus; HCV; hepatitis C virus; HDL; high-density lipoprotein; LDL; low-density lipoprotein; NAFLD; nonalcoholic fatty liver disease; NASH; nonalcoholic steatohepatitis; OCA;
Keywords: آسیب کبدی ناشی از مواد مخدر; Vildagliptin; Drug-induced liver injury; Hypersensitivity; Covalent binding; Nucleophilic trapping agents; ALG; alogliptin; ANG; anagliptin; CRP; C-reactive protein; CYP; cytochrome P450; DILI; drug-induced liver injury; DLST; drug-induced lymphocyte stim
Keywords: آسیب کبدی ناشی از مواد مخدر; Antibiotic; Nonsteroidal Anti-inflammatory; Pain Reliever; Diagnostic; DILI; drug-induced liver injury; iDILI; idiosyncratic drug-induced liver injury; MH cells; monocyte-derived hepatocyte-like cells; RUCAM; Roussel Uclaf Causality Assessment Method; ULN
Keywords: آسیب کبدی ناشی از مواد مخدر; Drug-induced liver injury; Hepatic failure; Viaminate;
Keywords: آسیب کبدی ناشی از مواد مخدر; DILI; Immune-mediated; Tolerance; Antigen; Immune cells homing; DILI; drug-induced liver injury; HLA; human leukocyte antigen; APCs; antigen presenting cells; DCs; dendritic cells; LSECs; liver sinusoidal endothelial cells; KCs; Kupffer cells; APAP; aceta
Keywords: آسیب کبدی ناشی از مواد مخدر; Acetaminophen; Drug-induced liver injury; Fibroblast growth factor 15; Liver regeneration;
Keywords: آسیب کبدی ناشی از مواد مخدر; Drug Induced Liver Injury; Drug Induced Liver Injury Network; Significant Alcohol Consumption; RUCAM; Chronic DILI; ALT; alanine aminotransferase; DILI; drug-induced liver injury; DILIN; Drug-induced Liver Injury Network; INR; international normalized rat
Keywords: آسیب کبدی ناشی از مواد مخدر; 2D-sw; 2D-sandwich; AMI; amiodarone; APAP; acetaminophen; BA; bile acid; BC; bile canaliculi; BOS; bosentan; BSEP; bile salt export pump; CPZ; chlorpromazine; CSA; cyclosporine A; CYP450; cytochrome P450; DIC; drug-induced cholestasis; DICI; drug-induced
Keywords: آسیب کبدی ناشی از مواد مخدر; Drug-induced liver injury; Leflunomide; Oxidative phosphorylation; ATP synthase; ANT;
Keywords: آسیب کبدی ناشی از مواد مخدر; EVs; extracellular vesicles; ALD; alcohol liver disease; ALT; alanine aminotransferase; CYP2E1; ethanol-inducible cytochrome P450-2E1; DILI; drug-induced liver injury; CCl4; carbon tetrachloride; AST; aspartate aminotransferase; hucMSC; human umbilical co
Keywords: آسیب کبدی ناشی از مواد مخدر; Acc; Accuracy; ADMET; absorption, distribution, metabolism, excretion, toxicity; AUC; area under the curve; BA; balanced accuracy; BCRP; breast cancer resistance protein; cpd(s); compound(s); CV; cross validation; DILI; drug-induced liver injury; EV; exte
Keywords: آسیب کبدی ناشی از مواد مخدر; ALF; acute liver failure; DHS; dapsone hypersensitivity syndrome; DIH; dapsone-induced hepatitis; DILI; drug-induced liver injury; INR; international normalized ratio;
Keywords: آسیب کبدی ناشی از مواد مخدر; Benzbromarone; Reactive metabolite; Glutathione adduct; Drug-induced liver injury; CYP; ABT; 1-aminobenzotriazole; BBR; benzbromarone; BSO; l-buthionine-sulfoximine; CYP; cytochrome P450; GSH; glutathione; HLM; human liver microsomes; HPLC; high-performan
Keywords: آسیب کبدی ناشی از مواد مخدر; Human ES/iPS cells; Drug-induced liver injury; Differentiation; Hepatocyte; Drug toxicity screening;
Keywords: آسیب کبدی ناشی از مواد مخدر; Hepersensitivity; Severe cutaneous adverse reactions; Drug-induced liver injury; Human leukocyte antigen; Reactive metabolites; Hapten concept; p-i concept; Altered peptide repertory concept; APC; antigen presenting cell; BB; Bandrowski's base; DILI; drug
Keywords: آسیب کبدی ناشی از مواد مخدر; Drug-induced liver injury; Venooclusive liver disease; Sinusoidal obstruction syndrome; Nodular regenerative hyperplasia; Autoimmune hepatitis; Radiation toxicity; Hepatitis B reactivation;
Keywords: آسیب کبدی ناشی از مواد مخدر; Drug-induced liver injury; Liver toxicity; Cirrhosis; Acute liver failure; Alcohol; Smoking;
Keywords: آسیب کبدی ناشی از مواد مخدر; Drug-induced liver injury; Jaundice, obstructive; Medicine, Chinese traditional; Creatinine; Hepatorenal syndrome;
Keywords: آسیب کبدی ناشی از مواد مخدر; Liver biopsy; Histopathology; Hepatotoxicity; Drug-induced liver injury;
Keywords: آسیب کبدی ناشی از مواد مخدر; Drug-induced liver injury; Acute liver failure; Chronic drug-induced liver injury;
Keywords: آسیب کبدی ناشی از مواد مخدر; AST; aspartate transaminase; BSA; bovine serum albumin; Cmax; maximal plasma concentration; DILI; drug-induced liver injury; EC50; half maximal effective concentration; GLDH; glutamate dehydrogenase; KH; Krebs-Henseleit; LDH; lactate dehydrogenase; NL; no
Keywords: آسیب کبدی ناشی از مواد مخدر; ADR; adverse drug reaction; COX; cyclooxygenase; DILI; drug-induced liver injury; DMTA; design-make-test-analyse; GI; gastrointestinal; iPSC; induced pluripotent stem cell; NSAID; non-steroidal anti-inflammatory drug; VOC; volatile organic compound; Gastr
Keywords: آسیب کبدی ناشی از مواد مخدر; Herbals; Dietary supplements; Liver; Toxicity; Drug-induced liver injury;
Keywords: آسیب کبدی ناشی از مواد مخدر; Hepatotoxicity; Drug-induced liver injury; Adverse drug reaction; Type A adverse drug reaction; Type B adverse drug reaction; Intrinsic; Idiosyncratic; LiverTox;
Keywords: آسیب کبدی ناشی از مواد مخدر; HIV; Drug-induced liver injury; Coinfections; Obesity; Low/high-income countries;
Keywords: آسیب کبدی ناشی از مواد مخدر; Drug-induced liver injury; Acute liver failure; Liver support systems; Artificial liver support systems; Bioartificial liver support systems;
Keywords: آسیب کبدی ناشی از مواد مخدر; Human liver models; Liver toxicology; Drug discovery; In vitro hepatotoxicity; Quantitative system pharmacology; Microphysiology liver; Drug-induced liver injury;
Keywords: آسیب کبدی ناشی از مواد مخدر; Drug-induced liver injury; Hepatotoxicity; Antibiotics; Antiretrovirals; Tyrosine kinase inhibitors; Monoclonal antibodies; Anticoagulants; Antiplatelet;
Keywords: آسیب کبدی ناشی از مواد مخدر; Database Analysis; Toxicity; Hepatotoxicity; Immune Response; Immunoglobulin; AIH; autoimmune hepatitis; Alk P; alkaline phosphatase; ALT; alanine aminotransferase; ANA; antinuclear antibody; AST; aspartate aminotransferase; DILI; drug-induced liver injur
Keywords: آسیب کبدی ناشی از مواد مخدر; Drug interactions; Hepatic transport; Transporters; ABC transporters; Bile acid transporters; BSEP; bile salt export pump; DILI; drug-induced liver injury; FXR; farnesoid X receptor; MDR; multidrug resistance protein; MRP; multidrug resistance-associated
Keywords: آسیب کبدی ناشی از مواد مخدر; Ornithine carbamoyltransferase; Drug-induced liver injury; Biomarker; Hepatocytes; Mitochondria; Drug development; Toxicity; Liver;
Keywords: آسیب کبدی ناشی از مواد مخدر; DILI; drug-induced liver injury; NPC; non-parenchymal cells; 2D-sw; 2D-sandwich; SM; safety margin; MT; microtissue; TC; training compound; Cryopreserved human hepatocytes; Monoculture and co-culture; DILI; In vitro models; Short term and long term exposu
Keywords: آسیب کبدی ناشی از مواد مخدر; DILI; drug-induced liver injury; ALT; alanine aminotransferase; ALP; alkaline phosphatase; BBW; black box warning; WDN; withdrawn; BC; bile canalicular; BSEP; bile salt export pump; MRP2; multidrug resistance-associated protein 2; SCHs; sandwich cultured
Keywords: آسیب کبدی ناشی از مواد مخدر; DILI; drug-induced liver injury; ALP; alkaline phosphatase; TB; total bilirubin; ULN; upper limit of normal; AST; aspartate aminotransferase; ALT; alanine aminotransferase; INR; international normalized ratio; R; ratio; HC; hepatocellular; Chol; cholestat
Keywords: آسیب کبدی ناشی از مواد مخدر; Statin; Adverse effects; Drug-drug interactions; Pharmacogenetics; ABC; ATP-binding cassette; ASCVD; atherosclerotic cardiovascular disease; CPIC; Clinical Pharmacogenetic Implementation Consortium; CK; creatinine kinase; CV; cardiovascular; CVD; cardio
Keywords: آسیب کبدی ناشی از مواد مخدر; RP; Raw Polygonum multiflorum L; PP; Processed Polygonum multiflorum L; HPLC-MS; high performance liquid chromatography-mass spectrometry; PCA; principal component analysis; PLS-DA; partial least squares discriminant analysis; VIP; variable importance par
Keywords: آسیب کبدی ناشی از مواد مخدر; Acute liver failure; Azole; Drug-induced liver injury; Hepatotoxicity;
Keywords: آسیب کبدی ناشی از مواد مخدر; Adverse drug reaction; drug-induced liver injury; hepatotoxicity; human leukocyte antigen; pharmacogenetics
Keywords: آسیب کبدی ناشی از مواد مخدر; Natalizumab; Hepatotoxicity; Autoimmune hepatitis; Drug-induced liver injury;
Keywords: آسیب کبدی ناشی از مواد مخدر; Drug-induced liver injury; Liver function tests; Herbal medicines; Conventional medicines; Safety; ALP; alkaline phosphatase; ALT; alanine aminotranferase; AST; aspartate aminotransferase; CIOMS; Council for International Organization of Medical Science;
Keywords: آسیب کبدی ناشی از مواد مخدر; Time-of-flight secondary ion MS; Imaging MS; Tissue imaging; Drug-induced liver injury; Acetaminophen;
Keywords: آسیب کبدی ناشی از مواد مخدر; CCD; Charge coupled devices; CMOS; Complementary metal-oxide semiconductors; DILI; Drug-induced liver injury; KC; Kupffer cell; LS; Laser scanning; LSEC; Liver sinusoidal endothelial cells; NET; Neutrophil extracellular traps; OPS; Orthogonal polarization
Keywords: آسیب کبدی ناشی از مواد مخدر; BA; bile acid; BEI; biliary excretion index; BSEP/Bsep; bile salt export pump; CsA; cyclosporine A; DILI; drug-induced liver injury; DMSO; dimethyl sulfoxide; E217βG; estradiol-17β-D-glucuronide; FBS; fetal bovine serum; GFP; green fluorescent protein;
Keywords: آسیب کبدی ناشی از مواد مخدر; Hepatotoxicity; Drug-induced liver injury; ALT elevation; Hyperbilirubinemia;
Keywords: آسیب کبدی ناشی از مواد مخدر; AIH; Autoimmune hepatitis; AMA; Anti-mitochondrial antibody; ANA; Anti-nuclear antibodies; APC; Antigen-presenting cell; APECED; Autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy; CTL; Cytotoxic T lymphocytes; DIL; Drug-induced liver injury;
Keywords: آسیب کبدی ناشی از مواد مخدر; DILI; drug-induced liver injury; HLA; human leucocyte antigen; DAMPs; the damage associated molecular pattern molecules; ADMET; absorption, distribution, metabolism, excretion and toxicity; GST; glutathione-S-transferase; ROS; reactive oxygen species; JNK
Keywords: آسیب کبدی ناشی از مواد مخدر; DILI; drug-induced liver injury; Mrp2; multidrug resistant protein 2; HCI; high content imaging; High content imaging; Rat hepatocytes; Hepatotoxicity; In vitro model; Long-term culture; Safety profiling;
Keywords: آسیب کبدی ناشی از مواد مخدر; Highly active antiretroviral therapy; Hepatitis; Fatty liver; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis; Metabolic syndrome; Drug-induced liver injury; Opportunistic infections;
Keywords: آسیب کبدی ناشی از مواد مخدر; Methotrexate; Liver; Hepatitis; Drug-induced liver injury; Meta-analysis;